On February 27, Ge Longhui Biotech (688193.SH) announced the 2023 Annual Results Report. During the reporting period, the company achieved operating income of 165 million yuan, a year-on-year decrease of 45.86%, and realized net profit attributable to owners of the parent company of 3.182,200 yuan, a year-on-year decrease of 86.36%; realized net profit attributable to the owner of the parent company after deducting non-recurring gains and losses of 125.903 million yuan, a year-on-year decrease of 354.89%.